Adma Biologics (ADMA) EBITDA Margin Growth (5y) (2016 - 2025)
Adma Biologics (ADMA) EBITDA Margin Growth (5y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - |
| 2 | Nanobiotix | 1,908.96 Bn | 1,908.90 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 474.03 Bn | 469.24 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.13 Bn | 114.88 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.09 Bn | 61.34 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.96 Bn | 50.77 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn |
| 10 | Adma Biologics | 2.05 Bn | 1.96 Bn | 88.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 16,848.00 |
| Sep 30, 2025 | 17,230.00 |
| Jun 30, 2025 | 25,497.00 |
| Mar 31, 2025 | 19,480.00 |
| Dec 31, 2024 | 9,782.00 |
| Sep 30, 2024 | 15,838.00 |
| Jun 30, 2024 | 19,855.00 |
| Mar 31, 2024 | 40,098.00 |
| Dec 31, 2023 | 42,720.00 |
| Sep 30, 2023 | 33,391.00 |
| Jun 30, 2023 | 28,958.00 |
| Mar 31, 2023 | 41,123.00 |
| Dec 31, 2022 | 7,494.00 |
| Sep 30, 2022 | 28,471.00 |
| Jun 30, 2022 | 23,492.00 |
| Mar 31, 2022 | 17,804.00 |
| Dec 31, 2021 | 9,455.00 |
| Sep 30, 2021 | 5,739.00 |
| Jun 30, 2021 | 15,432.00 |
| Mar 31, 2021 | 10,131.00 |